Search Results - "Proskurin, M A"

Clinical and economic analysis of Reslizumab use in the treatment of patients with severe allergic eosinophilic asthma by Kolbin, A S, Avdeev, S N, Zhuravleva, M V, Gomon, Yu M, Balykina, Yu E, Matveyev, N V, Proskurin, M A, Fedosenko, S V

“…Asthma is a heterogeneous chronic disease of airways. One of its endotypes is eosinophilic asthma, accompanied by both peripheral blood and airway…”
Get full text

Efficacy of alectinib in comparison with lorlatinib in patients with ALK-positive non-small cell lung cancer: pharmacoeconomic study by Kolbin, A. S., Gomon, Yu. M., Proskurin, M. A., Balykina, Yu. E.

“…Objective: to evaluate the clinical and economic effectiveness of alectinib in comparison with lorlatinib in adult patients with advanced anaplastic lymphoma…”
Get full text

Pharmacoeconomic analysis of fixed-duration targeted therapy regimens for chronic lymphocytic leukemia compared with therapy used until progression or intolerable toxicity by Kasimova, A. R., Kolbin, A. S., Proskurin, M. A., Balykina, Yu. E.

“…Background. Chronic lymphocytic leukemia (CLL) is a b-cell tumor of small b-lymphocytes. In CLL, significant lymphocytosis (5000 monoclonal b-lymphocytes) is…”
Get full text

The clinical-economic characteristic of current basis-bolus insulin therapy schemes in diabetes mellitus type 1 in adults by Kolbin, A. S., Kurilev, A. A., Balikina, Y. E., Proskurin, M. A.

“…Basis-bolus insulin therapy is a cornerstone of Diabetes Mellitus type 1 (DM1T) control. Basal insulin analogs — glargine 300 U/ml (iGla 300), glargine 100…”
Get full text

Clinical-economic analysis of the target therapy in severe atopic dermatitidis in adults by Kolbin, A. S., Gomon, Y. M., Proskurin, M. A., Balikina, Y. E.

“…Target therapy of severe atopic dermatitidis (AD) is actual because AD has a high prevalence and social-economic burden. Target therapy consists of monoclonal…”
Get full text

Pharmacoeconomic evaluation of ipragliflozin in combination with metformin in comparison with other regimens of therapy for type 2 diabetes mellitus by Kolbin, A. S., Kurylev, A. A., Balykina, Yu. E., Proskurin, M. A.

“…Ipragliflozin is a selective sodium-glucose cotransporter 2 (SGLT2) inhibitor that reduce plasma glucose concentrations by inhibiting glucose reabsorption by…”
Get full text

Clinical-economic evaluation of a screening for Pompe disease in children in the local conditions by Kolbin, A. S., Vilum, I. A., Balikina, Yu. E., Proskurin, M. A., Karpov, O. I.

“…Pompe disease with late onset (PDLO) can’t be diagnosed in time due to common symptoms with several neuro-muscular diseases. Screening and diagnostic measures…”
Get full text

Cystic fibrosis as a social-economic burden by Kolbin, A. S., Gomon, Yu. M., Karpov, O. I., Balykina, Yu. E., Proskurin, M. A.

“…Cystic fibrosis (CF) is a chronic genetic disease with social significant weight because it influences on social humanitarian part of health and on sources of…”
Get full text

Pharmacoeconomic analysis of atezolizumab plus nab-paclitaxel in the treatment of the advanced or metastatic triple-negative breast cancer by Kolbin, A S, Vilyum, I A, Proskurin, M A, Balikina, Yu E, Pavlysh, A V

“…Objective. To determine the pharmacoeconomical feasibility of using a combination of atezolizumab + nab-paclitaxel in the 1st line of therapy for locally…”
Get full text

Health-economic analysis of tocilizumab in patients with rheumatoid arthritis and systemic juvenile arthritis by Kolbin, A. S., Kurylev, A. A., Mishinova, S. A., Balykina, Yu. E., Proskurin, M. A.

“…Rationale. Rheumatoid arthritis (RA) and systemic juvenile arthritis (sJA) are the most frequent rheumatic diseases in adults and adolescents, consequently…”
Get full text

The social-economic burden of spinal muscular atrophy in Russia by Kolbin, A. S., Vlodavets, D. V., Kurylev, A. A., Balykina, Yu. Ye, Proskurin, M. A., Mishinova, S. A., Germanenko, O. Yu, Kolbina, N. Yu

“…Introduction. Spinal muscular atrophies (SMA) are clinically and genetically heterogeneous congenital orphan diseases that lead to progressive spinal…”
Get full text

Pharmacoeconomic analysis of using typical and atypical antipsychotics in schizophrenia by Vilyum, I. A., Andreev, B. V., Proskurin, M. A., Balykina, Yu. E.

“…The aim: to provide a comprehensive pharmacoeconomic evaluation of the maintenance therapy with antipsychotics in outpatients diagnosed with schizophrenia…”
Get full text

HEALTH ECONOMIC ASSESSMENT OF ANTIRHEUMATIC DRUGS IN PATIENTS WITH REUMATHOID ARTHRITIS PROGRESSED AFTER METOTREXATE by Kolbin, A. S., Kurylev, A. A., Proskurin, M. A., Balykina, Yu. E.

“…Objective. To perform health economic evaluation of several antirheumatic drugs in patients with rheumatoid arthritis (RA) progressed after DMARDs.Materials…”
Get full text

Pharmacoeconomic analysis of using mirabegron to treat overactive bladder in the setting of the Russian Federation health care by Kolbin, A S, Vilyum, I A, Proskurin, M A, Balykina, Yu E

“…The present paper presents, for the first time in Russia, a comparative pharmacoeconomic analysis of using mirabegron (Betmiga) to treat overactive bladder…”
Get more information

ANALYSIS OF CONSUMPTION OF ANTIBACTERIAL DRUGS FOR SYSTEMIC USE IN HOSPITALS OF SAINT PETERSBURG IN 2014–2015 by Gomon, Yu. M., Kurylev, A. A., Kolbin, A. S., Proskurin, M. A., Ivanov, I. G., Sidorenko, S. V., Arepieva, M. A., Sokolov, A. V.

“…Introduction . The overuse of antimicrobial agents, and poor adherence to infection control measures are leading factors in the development of bacterial…”
Get full text

Modeling microbial drug-resistance: from mathematics to pharmacoeconomics by Gomon, Yu. M., Arepyeva, M. A., Balykina, Yu. E., Kolbin, A. S., Kurylev, A. A., Proskurin, M. A., Sidorenko, S. V.

“…Complicated intra-abdominal infection (IAI) requires increased health care expenditures and additional resources to compensate for an ineffective starting…”
Get full text

Socio-economic burden of chronic graft-versus-host disease after allogenic bone marrow transplantation by Kolbin, A. S., Gomon, Yu. M., Proskurin, M. A., Balykina, Ju. E.

“…Aim . Chronic graft-versus-host disease (crGVHD) socio-economic burden assessment in the Russian Federation. Materials and methods . The assessment was…”
Get full text

Economic evaluation of insulin therapy intensification for effective and safe control of diabetes mellitus type 2 by A. S. Kolbin, A. A. Kurilev, Yu. E. Balikina, M. A. Proskurin, O. I. Karpov

“…Insulin therapy is one of the effective methods of effective control of diabetes mellitus type 2 (T2DM) which can manage resistance to insulin. Insulin’s…”
Get full text

Social-economic burden of Pompe disease with late onset in the Russian Federation by A. S. Kolbin, I. A. Vilyum, Yu. E. Balikina, M. A. Proskurin, O. I. Karpov

“…Pompe disease (PD) — a rare disease with progressive muscles weakness, cardiac and pulmonary insufficiency and others vital life-threatening symptoms without…”
Get full text

An update of pharmacoeconomic analysis of trastuzumab emtanzine in patients with HER2+ breast cancer and central nervous system metastases by A. S. Kolbin, A. A. Kurylev, Y. E. Balykina, M. A. Proskurin

“…Introduction. Regardless the pharmacoeconomic evaluation of trastuzumab emtanzine (T-DM-1) has been done before new data concerning T-DM1 effectiveness and…”
Get full text